{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:27:43Z","timestamp":1784154463572,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["PE0000006"],"award-info":[{"award-number":["PE0000006"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013465","name":"AFM-Telethon","doi-asserted-by":"publisher","award":["22199"],"award-info":[{"award-number":["22199"]}],"id":[{"id":"10.13039\/100013465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118767","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T21:40:16Z","timestamp":1763070016000},"page":"118767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6339-2222","authenticated-orcid":false,"given":"Paola","family":"Mantuano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1078-8490","authenticated-orcid":false,"given":"Brigida","family":"Boccanegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8914-2299","authenticated-orcid":false,"given":"Roberta","family":"Lenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisamaura","family":"Tulimiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"De Bellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-3118","authenticated-orcid":false,"given":"Jean-Alain","family":"Fehrentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5661-8382","authenticated-orcid":false,"given":"S\u00e9verine","family":"Denoyelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bresciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-676X","authenticated-orcid":false,"given":"Antonio","family":"Torsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1882-3502","authenticated-orcid":false,"given":"Ornella","family":"Cappellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2025.118767_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1360224","article-title":"The complex landscape of DMD mutations: moving towards personalized medicine","volume":"15","author":"Gatto","year":"2024","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib3","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200230","article-title":"The Persistence of Duchenne vs Becker Muscular Dystrophies: Vive la Difference?","volume":"11","author":"Hoffman","year":"2024","journal-title":"Neurol. Genet"},{"issue":"3","key":"10.1016\/j.biopha.2025.118767_bib4","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The Dystrophin Complex: Structure, Function, and Implications for Therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00007.2015","article-title":"Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy","volume":"96","author":"Allen","year":"2016","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.03.008","article-title":"Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy","volume":"31","author":"Grounds","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"21","key":"10.1016\/j.biopha.2025.118767_bib7","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/hmg\/ddu287","article-title":"Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in Duchenne muscular dystrophy","volume":"23","author":"Camerino","year":"2014","journal-title":"Hum. Mol. Genet"},{"issue":"4","key":"10.1016\/j.biopha.2025.118767_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1152\/japplphysiol.00776.2015","article-title":"Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points","volume":"122","author":"Capogrosso","year":"2017","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.biopha.2025.118767_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jprot.2017.09.009","article-title":"Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds","volume":"170","author":"Gamberi","year":"2018","journal-title":"J. Proteom."},{"issue":"4","key":"10.1016\/j.biopha.2025.118767_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/jcm10040820","article-title":"Innovative therapeutic approaches for duchenne muscular dystrophy","volume":"10","author":"Fortunato","year":"2021","journal-title":"J. Clin. Med"},{"issue":"9","key":"10.1016\/j.biopha.2025.118767_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003222","article-title":"CINRG VBP15 and DNHS Investigators. Efficacy and safety of vamorolone in Duchenne muscular dystrophy: an 18-month interim analysis of a non-randomized open-label extension study","volume":"17","author":"Smith","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","article-title":"Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?","volume":"16","author":"Kourakis","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"12","key":"10.1016\/j.biopha.2025.118767_bib13","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1172\/JCI39845","article-title":"Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice","volume":"119","author":"Heydemann","year":"2009","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.biopha.2025.118767_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.23819","article-title":"United Dystrophinopathy Project. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy","volume":"73","author":"Flanigan","year":"2013","journal-title":"Ann. Neurol."},{"issue":"610","key":"10.1016\/j.biopha.2025.118767_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf0376","article-title":"Anti-latent TGF\u03b2 binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy","volume":"13","author":"Demonbreun","year":"2021","journal-title":"Sci. Transl. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118767_bib16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/ijms21041242","article-title":"Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies","volume":"21","author":"Conte","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2025.118767_bib17","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/stem.2632","article-title":"Unacylated ghrelin enhances satellite cell function and relieves the dystrophic phenotype in duchenne muscular dystrophy mdx Model","volume":"35","author":"Reano","year":"2017","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13504-y","article-title":"Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia","volume":"7","author":"Sirago","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118767_bib19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jcsm.12185","article-title":"Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia","volume":"8","author":"Conte","year":"2017","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"key":"10.1016\/j.biopha.2025.118767_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1119888","article-title":"Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy","volume":"14","author":"Boccanegra","year":"2023","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118767_bib21","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","article-title":"Genetic background affects properties of satellite cells and mdx phenotypes","volume":"176","author":"Fukada","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet"},{"issue":"7","key":"10.1016\/j.biopha.2025.118767_bib23","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"van Putten","year":"2019","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70987-y","article-title":"The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy","volume":"10","author":"Hammers","year":"2020","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.biopha.2025.118767_bib25","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1073\/pnas.1324242111","article-title":"Annexin A6 modifies muscular dystrophy by mediating sarcolemmal repair","volume":"111","author":"Swaggart","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2025.118767_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1152\/physiolgenomics.00010.2006","article-title":"Fine mapping of Dyscalc1, the major genetic determinant of dystrophic cardiac calcification in mice","volume":"25","author":"Korff","year":"2006","journal-title":"Physiol. Genom."},{"issue":"3","key":"10.1016\/j.biopha.2025.118767_bib27","first-page":"47","article-title":"Diet replenishment for ad-libitum-fed mice housed in social groups is compatible with shelf life","volume":"47","author":"Huerkamp","year":"2008","journal-title":"J. Am. Assoc. Lab Anim. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118767_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00726-012-1355-2","article-title":"The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist","volume":"44","author":"Moulin","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.biopha.2025.118767_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104260","article-title":"Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies","volume":"145","author":"Sanarica","year":"2019","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118767_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105798","article-title":"BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading","volume":"171","author":"Mantuano","year":"2021","journal-title":"Pharm. Res"},{"issue":"11","key":"10.1016\/j.biopha.2025.118767_bib31","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/biom11111742","article-title":"\u03b2-Dystroglycan restoration and pathology progression in the dystrophic mdx mouse: outcome and implication of a clinically oriented study with a novel oral dasatinib formulation","volume":"11","author":"Mantuano","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.biopha.2025.118767_bib32","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/nu15020330","article-title":"Branched-chain amino acids and Di-alanine supplementation in aged mice: a translational study on sarcopenia","volume":"15","author":"Mantuano","year":"2023","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.biopha.2025.118767_bib33","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.3390\/ijms24054976","article-title":"Preclinical ultrasonography in rodent models of neuromuscular disorders: the state of the art for diagnostic and therapeutic applications","volume":"24","author":"Mele","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245397","article-title":"Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy","volume":"16","author":"Mele","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2025.118767_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310714","article-title":"Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse","volume":"19","author":"Boccanegra","year":"2024","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.biopha.2025.118767_bib36","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049930","article-title":"LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model","volume":"16","author":"Boccanegra","year":"2023","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.biopha.2025.118767_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1393746","article-title":"Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: new insights for nutritional interventions","volume":"15","author":"Conte","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118767_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.molimm.2021.10.010","article-title":"Circulating C1q levels in health and disease, more than just a biomarker","volume":"140","author":"van de Bovenkamp","year":"2021","journal-title":"Mol. Immunol."},{"issue":"8012","key":"10.1016\/j.biopha.2025.118767_bib39","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","article-title":"Refining the impact of genetic evidence on clinical success","volume":"629","author":"Minikel","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.biopha.2025.118767_bib40","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/jnnp.2005.078345","article-title":"E. The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy","volume":"77","author":"Witchel","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2025.118767_bib41","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.042903","article-title":"Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT)","volume":"13","author":"Willmann","year":"2020","journal-title":"Dis. Model Mech."},{"issue":"4","key":"10.1016\/j.biopha.2025.118767_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JND-180324","article-title":"\"Of Mice and Measures\": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic","volume":"5","author":"Gordish-Dressman","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2025.118767_bib43","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202317405","article-title":"Combinatorial activation of the WNT-dependent fibrogenic program by distinct complement subunits in dystrophic muscle","volume":"15","author":"Florio","year":"2023","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.biopha.2025.118767_bib44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-53886-y","article-title":"GSK3 inhibition improves skeletal muscle function and whole-body metabolism in male mouse models of Duchenne muscular dystrophy","volume":"15","author":"Marcella","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2025.118767_bib46","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41418-020-0551-y","article-title":"Adipogenesis of skeletal muscle fibro\/adipogenic progenitors is affected by the WNT5a\/GSK3\/\u03b2-catenin axis","volume":"27","author":"Reggio","year":"2020","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13539-012-0085-3","article-title":"Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model","volume":"4","author":"Lenk","year":"2013","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.biopha.2025.118767_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026865","article-title":"Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model","volume":"6","author":"Palus","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118767_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133276","article-title":"Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle","volume":"5","author":"Hammers","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.biopha.2025.118767_bib50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/WCO.0000000000000853","article-title":"The elusive promise of myostatin inhibition for muscular dystrophy","volume":"33","author":"Wagner","year":"2020","journal-title":"Curr. Opin. Neurol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:13:09Z","timestamp":1777014789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S0753332225009618"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118767","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118767"}}